Cargando…

Association Between Use of Antihyperlipidemic Agents and Chronic Obstructive Pulmonary Disease in Patients with Hyperlipidemia: A Population-Based Retrospective Cohort Study

OBJECTIVE: The effect of statins and fibrates on the risk of chronic obstructive pulmonary disease (COPD) remains unclear. The aim of this study was to investigate the effects of statins and fibrates on the risk of COPD in patients with hyperlipidemia. PATIENTS AND METHODS: This study involved a ret...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lei, Yi-Fen, Lin, Hsiu-Chen, Lin, Hsiu-Li, Uang, Yow-Sheng, Cheng, Hui-Wen, Wang, Li-Hsuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585814/ https://www.ncbi.nlm.nih.gov/pubmed/33116474 http://dx.doi.org/10.2147/COPD.S267017

Ejemplares similares

Association between Antihyperlipidemic Agent Use and Age-Related Macular Degeneration in Patients with Hyperlipidemia: A Population-Based Retrospective Cohort Study
por: Chen, Chun-Hao, et al.
Publicado: (2023)

Use of gastric acid–suppressive agents increases the risk of dementia in patients with upper gastrointestinal disease: A population-based retrospective cohort study
por: Lin, Hsiu-Chen, et al.
Publicado: (2021)

The use of proton pump inhibitors decreases the risk of diabetes mellitus in patients with upper gastrointestinal disease: A population-based retrospective cohort study
por: Lin, Hsiu-Chen, et al.
Publicado: (2016)

Association Between Acid-Suppressive Agents’ Use and Risk of Hepatocellular Carcinoma
por: Lin, Hsiu C., et al.
Publicado: (2020)

Association between statin use and the risk of gout in patients with hyperlipidemia: A population-based cohort study
por: Lin, Guan-Ling, et al.
Publicado: (2023)

Association Between Nonselective Beta-Blocker Use and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Without Cirrhosis and Decompensation
por: Cheng, He-Yun, et al.
Publicado: (2022)

Antihyperlipidemic potential of diosmin in Swiss Albino mice with high-fat diet induced hyperlipidemia
por: Firdous, Sayeed Mohammed, et al.
Publicado: (2021)

Antihyperlipidemic activity of Allium chinense bulbs
por: Lin, Yung-Pin, et al.
Publicado: (2016)

Pharmacological Screening of Trachyspermum ammi for Antihyperlipidemic Activity in Triton X-100 Induced Hyperlipidemia Rat Model
por: Saleem, Uzma, et al.
Publicado: (2017)

Antidiabetic and Antihyperlipidemic Effects of Sulphurenic Acid, a Triterpenoid Compound from Antrodia camphorata, in Streptozotocin-Induced Diabetic Mice
por: Lin, Cheng-Hsiu, et al.
Publicado: (2019)

Increased Risk of Chronic Obstructive Pulmonary Disease in Patients with Hyperlipidemia: A Nationwide Population-Based Cohort Study
por: Yang, Hao-Yu, et al.
Publicado: (2022)

Antidiabetic and Antihyperlipidemic Effects of Clitocybe nuda on Glucose Transporter 4 and AMP-Activated Protein Kinase Phosphorylation in High-Fat-Fed Mice
por: Chen, Mei-Hsing, et al.
Publicado: (2014)

Enhanced risk of traumatic brain injury in patients with chronic obstructive pulmonary disease
por: Huang, Tang-Hsiu, et al.
Publicado: (2020)

Potential Effect of Baobab’s Polyphenols as Antihyperlipidemic Agents: In Silico Study
por: Alameen, Alaa Alnoor, et al.
Publicado: (2023)

Antihyperlipidemic and Antioxidant Effects of C-phycocyanin in Golden Syrian Hamsters Fed with a Hypercholesterolemic Diet
por: Sheu, Ming-Jyh, et al.
Publicado: (2013)

Risk of Hyperlipidemia in Women with Hysterectomy-A Retrospective Cohort Study in Taiwan
por: Li, Pei-Chen, et al.
Publicado: (2018)

Combining antihypertensive and antihyperlipidemic agents – optimizing cardiovascular risk factor management
por: Zamorano, José, et al.
Publicado: (2011)

Exploring simvastatin, an antihyperlipidemic drug, as a potential topical antibacterial agent
por: Thangamani, Shankar, et al.
Publicado: (2015)

Increased Risk of Acute Pancreatitis in Patients with Rheumatoid Arthritis: A Population-Based Cohort Study
por: Chang, Chi Ching, et al.
Publicado: (2015)

Association between GnRH analogue use and atopic diseases in patients with prostate cancer: A population-based retrospective cohort study
por: Lin, Sheng-Feng, et al.
Publicado: (2022)

Eburicoic Acid, a Triterpenoid Compound from Antrodia camphorata, Displays Antidiabetic and Antihyperlipidemic Effects in Palmitate-Treated C2C12 Myotubes and in High-Fat Diet-Fed Mice
por: Lin, Cheng-Hsiu, et al.
Publicado: (2017)

Antidiabetic and antihyperlipidemic activities of Phyllanthus emblica L. extract in vitro and the regulation of Akt phosphorylation, gluconeogenesis, and peroxisome proliferator-activated receptor α in streptozotocin-induced diabetic mice
por: Huang, Shin-Ming, et al.
Publicado: (2023)

Development and validation of an LC–MS/MS method for quantification of NC-8 in rat plasma and its application to pharmacokinetic studies
por: Kachingwe, Baxter Hepburn, et al.
Publicado: (2017)

Mitotane-Induced Hyperlipidemia: A Retrospective Cohort Study
por: Shawa, Hassan, et al.
Publicado: (2013)

Antcin K, a Triterpenoid Compound from Antrodia camphorata, Displays Antidiabetic and Antihyperlipidemic Effects via Glucose Transporter 4 and AMP-Activated Protein Kinase Phosphorylation in Muscles
por: Kuo, Yueh-Hsiung, et al.
Publicado: (2016)

Pharmacokinetic Study of a Novel Antihyperlipidemic Agent LM-13765- A Prodrug
por: Shah, T. M., et al.
Publicado: (2009)

The Antihyperlipidemic Mechanism of High Sulfate Content Ulvan in Rats
por: Qi, Huimin, et al.
Publicado: (2015)

Irritable bowel syndrome increases the risk of chronic obstructive pulmonary disease: A retrospective cohort study
por: Lai, Hsiang-Chun, et al.
Publicado: (2020)

Docking study of novel antihyperlipidemic thieno[2,3-d]pyrimidine; LM-1554, with some molecular targets related to hyperlipidemia - an investigation into its mechanism of action
por: Khedkar, Vijay M, et al.
Publicado: (2014)

Soluble Dietary Fibers as Antihyperlipidemic Agents: A Comprehensive Review to Maximize Their Health Benefits
por: Bakr, Alaa F., et al.
Publicado: (2023)

Effects of Bofu-Tsusho-San on Diabetes and Hyperlipidemia Associated with AMP-Activated Protein Kinase and Glucose Transporter 4 in High-Fat-Fed Mice
por: Lin, Cheng-Hsiu, et al.
Publicado: (2014)

Chronic Obstructive Pulmonary Disease and Dysphagia: A Synergistic Review
por: Lin, Ting-fen, et al.
Publicado: (2020)

Extraction of Radix trichosanthis Polysaccharides for Potential Antihyperlipidemic Application
por: Chen, Fujia, et al.
Publicado: (2022)

Population-based retrospective cohort study on risk of age-related macular degeneration in people with chronic obstructive pulmonary disease
por: Bair, Pei-Jane, et al.
Publicado: (2021)

The antihyperlipidemic effects of fullerenol nanoparticles via adjusting the gut microbiota in vivo
por: Li, Juan, et al.
Publicado: (2018)

An Insight into Antihyperlipidemic Effects of Polysaccharides from Natural Resources
por: Jing, Yong-Shuai, et al.
Publicado: (2022)

Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study
por: Huang, Tang-Hsiu, et al.
Publicado: (2021)

Pharmacological Screening of Annona cherimola for Antihyperlipidemic Potential
por: Verma, Adarsh M, et al.
Publicado: (2011)

Phytochemical analysis, antioxidant, and antihyperlipidemic activities of Teucriumtakoumitense
por: El-Guourrami, Otman, et al.
Publicado: (2023)

Correction to: Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study
por: Huang, Tang-Hsiu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4p50oqd4ulds2a9nl8jf1n3itj